Title: Long-term efficacy of mepolizumab at 3 years in patients with severe asthma: comparison with clinical trials and super responders.
Citation: Biomedicines
2023;11:2424.
Country: Italy | Indication: Asthma
http://tago.ca/37760865
Title: Long-term efficacy of mepolizumab at 3 years in patients with severe asthma: comparison with clinical trials and super responders.
Citation: Biomedicines
2023;11:2424.
Country: Italy | Indication: Asthma
Title: Long-term efficacy of mepolizumab at 3 years in patients with severe asthma: comparison with clinical trials and super responders.
Citation: Biomedicines
2023;11:2424.
Country: Italy | Indication: Asthma